Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 591

Results For "IND"

6841 News Found

Moderna Covid-19 boosters after five-month interval: U.S. FDA
News | January 08, 2022

Moderna Covid-19 boosters after five-month interval: U.S. FDA

Earlier last week the U.S. FDA had also shortened the time to receive a Pfizer booster shot from six months to five months for everyone 12 and older


Maharasthra Health Minister inaugurates BSV research centre at Airoli, Maharashtra
Biotech | January 07, 2022

Maharasthra Health Minister inaugurates BSV research centre at Airoli, Maharashtra

The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems


SyneuRx oral Covid-19 anti-viral drug Pentarlandir shows promise against Delta and Omicron
Biotech | January 07, 2022

SyneuRx oral Covid-19 anti-viral drug Pentarlandir shows promise against Delta and Omicron

Acting as both a Dual Protease and TMPRSS2 Inhibitor, Pentarlandir is about to enter FDA Phase III trial¬


Lupin launches Molnulup to treat Covid-19
News | January 07, 2022

Lupin launches Molnulup to treat Covid-19

The drug is priced at Rs 2000 for a course of 40 tablets


Jubiant Therapeutics gets USFDA clearance for JBI-802 to treat solid tumours
Biotech | January 07, 2022

Jubiant Therapeutics gets USFDA clearance for JBI-802 to treat solid tumours

JBI-802 is a novel, oral, potent and selective dual inhibitor of two epigenetic targets of the CoREST complex: LSD1 and HDAC6


Merck KGaA to acquire biopharma CDMO Exelead for $780 million
Biotech | January 07, 2022

Merck KGaA to acquire biopharma CDMO Exelead for $780 million

The transaction is expected to close in the first quarter of 2022


Barentz appoints Daniel Hitz as CEO, APAC
People | January 07, 2022

Barentz appoints Daniel Hitz as CEO, APAC

Hitz shall assume new role from January 17th, 2022


Margins under pressure; domestic market growth to slow down: Nirmal Bang
News | January 06, 2022

Margins under pressure; domestic market growth to slow down: Nirmal Bang

A preview on Q3FY22 by Nirmal Bang Securities on select Indian pharma companies


Yashoda Hospitals performs region’s first double-lung transplant
Hospitals | January 06, 2022

Yashoda Hospitals performs region’s first double-lung transplant

After double lung transplantation, he was discharged without supplemental oxygen on the eleventh day


Thermo Fisher Scientific acquires PeproTech for US $1.85 bn
Medical Device | January 06, 2022

Thermo Fisher Scientific acquires PeproTech for US $1.85 bn

PeproTech's recombinant proteins portfolio complements Thermo Fisher's cell culture media products